Tetra Bio Pharma Inc (TBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 11-2018 | 08-2018 | 05-2018 | 02-2018 | 11-2017 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2 | 2 | 2 | 2 | 2 |
| Accounts receivable | -186 | -211 | -110 | -58 | -29 |
| Other Working Capital | 1,593 | -681 | 276 | -49 | 312 |
| Other Operating Activity | -4,293 | -1,744 | -2,627 | -1,421 | -486 |
| Operating Cash Flow | $-2,885 | $-2,634 | $-2,460 | $-1,526 | $-201 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 0 | 350 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -500 |
| Investing Cash Flow | $0 | $350 | $N/A | $N/A | $-500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,302 | 805 | N/A | N/A | 0 |
| Other Financing Activity | 906 | 105 | 14,199 | 716 | 877 |
| Financing Cash Flow | $7,208 | $910 | $14,199 | $716 | $877 |
| Beginning Cash Position | 9,262 | 10,637 | 1,382 | 2,193 | 2,017 |
| End Cash Position | 13,586 | 9,262 | 10,637 | 1,382 | 2,193 |
| Net Cash Flow | $4,323 | $-1,374 | $9,254 | $-811 | $176 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,885 | -2,634 | -2,460 | -1,526 | -201 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -500 |
| Free Cash Flow | -2,885 | -2,634 | -2,460 | -1,526 | -701 |